Journal: PLoS ONE
Article Title: The Related Transcriptional Enhancer Factor-1 Isoform, TEAD4 216 , Can Repress Vascular Endothelial Growth Factor Expression in Mammalian Cells
doi: 10.1371/journal.pone.0031260
Figure Lengend Snippet: Transient plasmid transfection or stable lentiviral mediated introduction of TEAD4 216 into human cells results in reduction of native VEGF protein. Solid bars represent VEGF 165 levels, quantified by ELISA, within conditioned media collected 48 hours after transfection of pcDNA plasmid vector containing the TEAD4 216 isoform into ( A ) 293T cells, ( B ) ARPE-19 retinal pigment epithelial (RPE) cells in culture (n = 4), (p<0.05). ( C ) Lentiviral (LV) expression of the TEAD4 216 isoform in human D407 RPE cells can inhibit endogenous VEGF production. Solid bars represent VEGF 165 levels, quantified by ELISA, within conditioned media collected 48 hours after transduced RPE cells were FAC sorted and plated (n = 3),(p<0.02).
Article Snippet: TEAD4 was visualized in tissue sections, according to a previously published indirect immunostaining method , using rabbit polyclonal anti-TEAD4 antibody (made to order by Genemed Synthesis, San Antonio, TX, see for details of custom made antibody) or, as negative control, rabbit IgG (Vector Laboratories, Burlingame, CA), at a concentration of 11 ug/mL.
Techniques: Plasmid Preparation, Transfection, Enzyme-linked Immunosorbent Assay, Expressing